January 22, 2019
Wren Therapeutics bags £18 million in Series A financing round
Wren Therapeutics has cashed in £18 million from an international syndicate led by The Baupost Group, in a Series A financing round, which also included LifeForce Capital and a number of high net worth individual investors, the company said Tuesday.